Premium
Expression of Nestin and IGF‐1 in Rat Pancreas after Streptozotocin Administration
Author(s) -
Nagasao J.,
Yoshioka K.,
Amasaki H.,
Mutoh K.
Publication year - 2004
Publication title -
anatomia, histologia, embryologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.34
H-Index - 35
eISSN - 1439-0264
pISSN - 0340-2096
DOI - 10.1111/j.1439-0264.2004.00495.x
Subject(s) - streptozotocin , nestin , medicine , endocrinology , pancreas , islet , pancreatic islets , enteroendocrine cell , receptor , insulin , chemistry , biology , diabetes mellitus , endocrine system , stem cell , microbiology and biotechnology , hormone , neural stem cell
Summary The present study examines whether centroacinar (CA) and intercalated duct (ICD) cells can serve as stem cells, after administration of the diabetogenic agent streptozotocin (STZ). Thirty rats were divided into five experimental groups: (1) control, (2) 1 day after STZ (STZ‐1), (3) 3 days after STZ (STZ‐3), (4) 7 days after STZ (STZ‐7) and (5) 14 days after STZ (STZ‐14). Many small pancreatic islets were observed in the STZ‐7 group than in the other experimental groups, and many of these small islets were in close contact with ICD and CA cells. A higher number of nestin, insulin‐like growth factor‐1 (IGF‐1) and IGF‐1‐receptor positive ICD and CA cells were observed at STZ‐3 and STZ‐7 than at the others. These expression patterns coincided well with the proliferating cell nuclear antigen pattern. The results suggest that rat pancreatic endocrine cells after damage by STZ administration might be recovered from newly generated cells derived from ICD and CA cells.